Affiliation:
1. Deparment of Orthopedics, Xiangya Hospital Central South University Changsha China
2. Xiangya School of Medicine Central South University Changsha China
3. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University Changsha China
Abstract
AbstractBackgroundThe Journal of Cachexia, Sarcopenia and Muscle is a quarterly peer‐reviewed medical journal published by WILEY since 2010 and has been dedicated to advancing research on chronic diseases, especially cachexia and sarcopenia. Over the past 12 years, sarcopenia research worldwide has significantly changed. This study aimed to investigate different aspects of studies published in this journal.MethodsUsing the term ‘Journal of Cachexia, Sarcopenia and Muscle’, we retrieved related publications from the Web of Science and PubMed databases. Studies published in this journal were classified and analysed from different perspectives, such as the number of studies, total citations, times cited per item, H‐index, research area, article types, institutions, country and funding agency. The VOS viewer software was used for co‐occurrence, bibliographic coupling, co‐citation and co‐authorship analyses.ResultsFrom 2010 to 2022, 1194 studies were published in the Journal of Cachexia, Sarcopenia and Muscle. The United States was the highest contributor, with the most publications and citations and the highest H‐index. Italy ranked first for the times cited per item. The main research area was geriatrics and gerontology. von Haehling S was the author with the highest impact. The National Institutes of Health, USA, and the United States Department of Health Human Services funded the maximum number of studies. The top 5 most frequently used keywords in all publications over 12 years were sarcopenia, cachexia, skeletal muscle, body composition and muscle mass. The Journal of Cachexia, Sarcopenia and Muscle was cited the most by Nutrients, and PLOS ONE was cited the most by the Journal of Cachexia, Sarcopenia and Muscle.ConclusionsPublications in the Journal of Cachexia, Sarcopenia and Muscle have significantly increased from 2010 to 2022, especially in recent years. The United States is still the leader in sarcopenia research. Future submissions to this journal will continue to focus on sarcopenia, cachexia, skeletal muscle, body‐composition and muscle mass. The aetiology, molecular mechanisms and outcomes of sarcopenia and cachexia are current research hotspots.
Funder
National Natural Science Foundation of China
National Key Research and Development Program of China
Natural Science Foundation of Hunan Province
Wu Jieping Medical Foundation